4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-20-008070
Chief Medical Officer acquired 17,231 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Detke Michael J. Chief Medical Officer | 2020-02-07 | Option exercise | +17,231 | $6.91 | $119,066 | 17,231 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Detke Michael J. Chief Medical Officer | 2020-02-06 | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | D: show line 2 in the form | ||
| Detke Michael J. Chief Medical Officer | 2020-02-07 | Option exercise · Stock Option (Right to Buy) | −17,231 | 115,121 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…